CBT Stock Analysis: Buy, Sell, or Hold?
CBT - Cabot Corporation
$86.35
-0.35 (-0.40%)
▼
5d:
-7.24%
30d:
-1.09%
90d:
+14.69%
HOLD
LOW Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 03, 2026
29d
Get Alerted When CBT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CBT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: CBT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$107.90
Based on 7.4% avg growth
INTRINSIC VALUE TODAY
$67.00
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CBT is currently trading at $86.35, which is considered fair relative to its 30-day fair value range of $84.27 to $90.64. From a valuation perspective, the stock is trading at a premium (Forward PE: 12.3) compared to its historical average (10.8). At these levels, the market is pricing in 4.7% annual earnings growth.
Technical Outlook: Technically, CBT is in a strong uptrend. The price is currently testing key support at $85.06. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CBT is in a strong uptrend. The price is currently testing key support at $85.06. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$84.27 -
$90.64
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
71.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($88.50)
- BULLISH: Expecting earnings turnaround to 4.7% growth with -3.4% revenue growth
- CAUTION: Recommendation downgraded due to -7.2% 5-day decline
Trading Range Analysis
30-Day Trading Range
$84.27 -
$90.64
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$85.06
Resistance Level
$94.53
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.34
Wall Street Target
$88.50
(+2.5%)
Revenue Growth (YoY)
-3.4%
Earnings Growth (YoY)
-24.9%
Profit Margin
8.0%
Valuation Premium vs History
+4.7% premium
PE vs Historical
12.3 vs 10.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.7%
(market-implied from PE analysis)
1-Year Target
$90.41
(+5%)
2-Year Target
$94.66
(+10%)
3-Year Target
$99.11
(+15%)
3-Yr Target (if PE normalizes)
(PE: 12→11)
PE COMPRESSION
$86.77
(+1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 10.8%)
$207.65
(+141%)
Base:
(SPY PE: 12.3, Growth: 10.8%)
$117.61
(+36%)
Bear:
(PE: 10.5, Growth: 10.8%)
$99.97
(+16%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (16x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 16.36 | Current EPS (TTM): $5.30
Bull Case
$125.96
(+46%)
Analyst growth 32.1%, PE expands to 18.0
Base Case
$114.51
(+33%)
Market implied 32.1%, PE stable at 16.4
Bear Case
$58.96
(-32%)
Severe decline -20.0%, PE contracts to 13.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 04, 2026 2:30 AM ET
Data refreshes hourly during market hours. Next update: 3:30 AM
Data refreshes hourly during market hours. Next update: 3:30 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CBT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Specialty Chemicals Stocks
Top-rated stocks in Specialty Chemicals by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ECL
Ecolab Inc |
STRONG BUY
27 analysts |
$317 | 64 BUY |
|
LIN
Linde plc Ordinary Shares |
BUY
28 analysts |
$546 | 62 BUY |
|
SHW
Sherwin-Williams Co |
BUY
28 analysts |
$374 | 60 BUY |
|
APD
Air Products and Chemica… |
BUY
24 analysts |
$328 | 65 BUY |
|
IFF
International Flavors & … |
STRONG BUY
19 analysts |
$91 | 63 BUY |
